None listed
Conditions
Sponsors
Morinaga & Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy males and females aged 20 - 39 years. 2) Individuals who are healthy and are not suffered from a chronic malady. 3) Individuals who are able to come to the clinic and take the examination on the specified day. 4) Individuals who are fully informed about this study, have the ability to agree, participate voluntarily with good understanding, and agree informed consent in writing. 4) Individuals who can visit an inspection facility and be inspected in designated days. 5) Individuals who can draw blood from a fingertip. 6) Individuals judged appropriate for this study by the principal investigator.
Exclusion criteria
Exclusion criteria: 1) Individuals using medical products. 2) Individuals who used a drug for treatment of disease in the past 1 month. 3) Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. 4) Individuals who contract or have a history of serious gastrointestinal disease. 5) Individuals with serious anemia. 6) Individuals who contract or have a history of food allergy. (milk, gelatin) 7) Females who are or are possibly pregnant, or are lactating. 8) Individuals who have an addiction to alcohol or a mental illness. 9) Individuals who are a smoker. 10) Individuals with high blood glucose (fasting blood glucose over 110 mg/dL). 11) Individuals whose life style will change during the test period. 12) Individuals with probable seasonal allergy, such as pollinosis, during the test period.(Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae:Dactylis glomerata, Phleum pratense) 13) )Individuals who had a habit to ingest foods claiming to effect on blood glucose level improvement , foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 14) Individuals who have a habit to use drug claiming to effect on blood glucose level improvement in the past 3 months. 15) Individuals who conducted hormone replacement therapy in the past 6 months or have a history of conducting hormone replacement therapy. 16) Individuals who were hospitalized and received treatment in the past 6 months, or will be hospitalized during the test period. 17) Individuals who participated in other clinical studies in the past 1 months. 18) Individuals judged inappropriate for the study by the principal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose levels | — |
Countries
Japan
Contacts
Public ContactEriko Saito
Morinaga & Co., Ltd. Health Science and Research Center, R&D institute
Outcome results
None listed